XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
W
W

Walgreens

Actualités

Reuters - Il y a 1 jour

Baltimore to take drug distributors to trial over opioids

UPDATE 1-Baltimore to take drug distributors to trial over opioids Adds comment from Cencora in paragraph 4 By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.
T
W
M
Reuters - Il y a 1 jour

Baltimore to take drug distributors to trial over opioids

CORRECTED-Baltimore to take drug distributors to trial over opioids Corrects headline and lead, adds paragraphs 4-5 to state that J&J settled before trial By Brendan Pierson Sept 16 (Reuters) - The city of Baltimore is scheduled to go to trial this week in its $11 billion lawsuit accusing drug distributors McKesson MCK.N and Cencora COR.N of fueling an epidemic of opioid addiction and overdose deaths.
T
W
M
Reuters - Il y a 4 jours

Walgreens paying $106.8 million to settle US prescription billing fraud charges

UPDATE 3-Walgreens paying $106.8 million to settle US prescription billing fraud charges Adds Justice Department comment, share price, paragraphs 4, 13 By Jonathan Stempel Sept 13 (Reuters) - Walgreens Boots Alliance WBA.O agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday.
W
Reuters - Il y a 4 jours

CORRECTED Walgreens paying $106.8 million to settle US prescription billing fraud charges

CORRECTED (OFFICIAL)-UPDATE 2-Walgreens paying $106.8 million to settle US prescription billing fraud charges Corrects paragraph 3 to remove discussion of Walgreens reselling prescriptions and effectively being paid twice, after U.S. Department of Justice corrects press release to remove that accusation By Jonathan Stempel Sept 13 (Reuters) - Walgreens Boots Alliance WBA.O agreed to pay $106.8 million to settle charges it fraudulently billed the U.S.
W
Reuters - Il y a 4 jours

Walgreens agrees to pay $106.8 mln to settle US charges over prescription billing

Walgreens agrees to pay $106.8 mln to settle US charges over prescription billing Sept 13 (Reuters) - Walgreens Boots Alliance WBA.O agreed to pay $106.8 million to settle charges it billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday. The Justice Department said that from 2009 to 2020, Walgreens submitted false claims for payment to Medicare, Medicaid and other federal health care programs for prescriptions it processed but which were
W
Reuters - Il y a 5 jours

UK's Boots names Anthony Hemmerdinger as new boss

UK's Boots names Anthony Hemmerdinger as new boss LONDON, Sept 12 (Reuters) - British health and beauty retailer Boots has promoted Anthony Hemmerdinger to the managing director role, succeeding Seb James on Nov. 4, it said on Thursday. Boots UK, owned by U.S. listed Walgreens Boots Alliance WBA.O , is one of Britain's biggest retailers, trading from about 1,900 stores and employing 52,000. Hemmerdinger, a former Asda supermarket executive, has been Boots UK's retail and operations director sinc
W
Reuters - Il y a 1 semaine

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

UPDATE 1-Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial Adds comment from J&J in paragraph 6 By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.
T
W
M
Reuters - Il y a 1 semaine

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial

Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial By Brendan Pierson Sept 10 (Reuters) - Baltimore said on Tuesday that it has settled with Walgreens WBA.O over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week.
T
W
M
Reuters - Il y a 1 semaine

Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal

BUZZ-Jefferies cuts PT on drug distributor McKesson, raises PT on Cardinal ** Brokerage Jefferies cuts PT on drug distributor McKesson MCK.N to $607 from $630, while raising PT on peer Cardinal Health CAH.N to $110 from $105 ** Says despite MCK forecasting Q2 below estimates, co's reiteration of full-year forecast gives "some level of confidence" *
W
M
Reuters - Il y a 1 semaine

From Boeing to Detroit Three, US labor unions flex muscle

From Boeing to Detroit Three, US labor unions flex muscle Changes headline, recasts paragraph 1, adds Boeing labor deal in paragraph 14 By Mrinalika Roy Sept. 8 (Reuters) - U.S. planemaker Boeing .N> has averted a possible strike after reaching a tentative labor deal with a union representing more than 32,000 workers in the U.S. Pacific Northwest, the latest in a series of labor negotiations that brought double-digit wage increases despite a tight labor market and stubborn inflation.
B
J
S
V
W
U
A
U
W
Reuters - Il y a 2 semaines

Walgreens hit with lawsuit claiming generic cold medicine has cancer-causing chemical

Walgreens hit with lawsuit claiming generic cold medicine has cancer-causing chemical By Diana Novak Jones Sept 4 (Reuters) - Walgreens is facing a proposed class action lawsuit brought on Wednesday by customers who say they weren’t warned that the pharmacy chain’s generic version of cold medicine Mucinex contains a cancer-causing chemical. The lawsuit, filed in Chicago federal court, claims Walgreens did not label the products or otherwise warn customers that they contained benzene, a known
W
Reuters - Il y a 2 semaines

U.S. STOCKS Dyne Therapeutics, Maxeon Solar, chip stocks

BUZZ-U.S. STOCKS ON THE MOVE-Dyne Therapeutics, Maxeon Solar, chip stocks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell over 1% on Tuesday as investors assessed subdued factory activity data ahead of a slew of labor market reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve.
B
C
C
G
I
M
N
N
R
T
W
A
U
R
U
U
U
S
T
X
I
M
M
R
Reuters - Il y a 2 semaines

Intel's Dow status under threat as struggling chipmaker's shares plunge

GRAPHIC-Intel's Dow status under threat as struggling chipmaker's shares plunge Updates shares in paragraph 3; Adds details on chip sales, analyst comment and background in paragraphs 8-10 By Arsheeya Bajwa Sept 3 (Reuters) - Intel was one of the first two tech companies to join the Dow Jones Industrial Average during the late-'90s dot-com boom, along with Microsoft.
A
I
M
N
U
W
T
U
U
Reuters - Il y a 2 semaines

U.S. STOCKS Walgreens, Copper miners, Simon Property

BUZZ-U.S. STOCKS ON THE MOVE-Walgreens, Copper miners, Simon Property Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell over 1% as investors assessed latest factory activity data, with a slew of labor market reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve this year.
B
C
C
G
N
R
T
W
U
R
U
U
S
X
A
I
M
M
R
Reuters - Il y a 2 semaines

'Murky' path forward for Walgreens, Leerink Partners says

BUZZ-'Murky' path forward for Walgreens, Leerink Partners says Updates ** Brokerage Leerink Partners cuts PT on drugstore chain Walgreens Boots Alliance WBA.O to $9 from $11 ** Shares of Walgreens down 1.4% in early trading ** Company faces significantly higher interest expense in FY26 and FY27 and years of sales-leasebacks may complicate WBA's store closure plan, weighing on its cost-reduction efforts - brokerage ** WBA in June cut its FY24 profit forecast and said it would close underperformin
W
Reuters - Il y a 2 semaines

U.S. STOCKS Boeing, Southwest Airlines, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Southwest Airlines, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a lower open on Tuesday as investors moved to the sidelines ahead of a slew of economic data reports due through the week that could influence the extent of monetary policy easing by the Federal Reserve this year.
B
C
N
T
W
U
R
U
X
I
M
Reuters - Il y a 2 semaines

'Murky' path forward for Walgreens, Leerink Partners says

BUZZ-'Murky' path forward for Walgreens, Leerink Partners says ** Brokerage Leerink Partners cuts PT on drugstore chain Walgreens Boots Alliance WBA.O to $9 from $11 ** "More potential storm clouds loom on the horizon" for WBA, says brokerage ** Co faces significantly higher interest expense in FY26 and FY27 and years of sales-leasebacks may complicate the WBA's store closure plan, weighing on company's cost reduction efforts - brokerage ** WBA had cut its FY24 profit forecast and said it would
W
Reuters - Il y a 2 semaines

Intel's Dow status under threat as struggling chipmaker's shares plunge

GRAPHIC-Intel's Dow status under threat as struggling chipmaker's shares plunge By Arsheeya Bajwa Sept 3 (Reuters) - Intel was one of the first two tech companies to join the Dow Jones Industrial Average during 1999's dot-com era, along with Microsoft. Now, a slump in its share price could cost the American chipmaker its place in the blue-chip index.
A
I
M
N
W
T
U
U
Reuters - Il y a 3 semaines

U.S. Autodesk, Elastic NV, GMS

U.S. RESEARCH ROUNDUP-Autodesk, Elastic NV, GMS Aug 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Autodesk, Elastic NV and GMS, on Friday. HIGHLIGHTS * Autodesk Inc ADSK.O : RBC raises target price to $313 from $290 * Elastic NV ESTC.N : Piper Sandler cuts target price to $100 from $131 * GMS Inc GMS.N : Truist Securities cuts target price to $90 from $95 * Nvidia Corp NVDA.O : Baird raises target price to $150 f
A
G
M
N
N
W
C
D
U
D
S
Reuters - Il y a 3 semaines

U.S. STOCKS Lumen Technologies, Insulet, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 rose on Tuesday in mixed trading ahead of a highly anticipated quarterly report from Nvidia and economic data expected later in the week.
N
W
U
U
C
M
R

Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques